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That Are Required for Different Protein Interactions
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RAP1 is a telomere protein that is well conserved from protozoa to
mammals. It plays important roles in chromosome end protection, telomere length
control, and gene expression/silencing at both telomeric and nontelomeric loci. Interaction with different partners is an important mechanism by which RAP1 executes
its different functions in yeast. The RAP1 ortholog in Trypanosoma brucei is essential
for variant surface glycoprotein (VSG) monoallelic expression, an important aspect of
antigenic variation, where T. brucei regularly switches its major surface antigen, VSG,
to evade the host immune response. Like other RAP1 orthologs, T. brucei RAP1
(TbRAP1) has conserved functional domains, including BRCA1 C terminus (BRCT),
Myb, MybLike, and RAP1 C terminus (RCT). To study functions of various TbRAP1 domains, we established a strain in which one endogenous allele of TbRAP1 is ﬂanked
by loxP repeats, enabling its conditional deletion by Cre-mediated recombination.
We replaced the other TbRAP1 allele with various mutant alleles lacking individual
functional domains and examined their nuclear localization and protein interaction
abilities. The N terminus, BRCT, and RCT of TbRAP1 are required for normal protein
levels, while the Myb and MybLike domains are essential for normal cell growth. Additionally, the Myb domain of TbRAP1 is required for its interaction with T. brucei
TTAGGG repeat-binding factor (TbTRF), while the BRCT domain is required for its
self-interaction. Furthermore, the TbRAP1 MybLike domain contains a bipartite nuclear localization signal that is required for its interaction with importin ␣ and its nuclear localization. Interestingly, RAP1’s self-interaction and the interaction between
RAP1 and TRF are conserved from kinetoplastids to mammals. However, details of
the interaction interfaces have changed throughout evolution.
ABSTRACT

IMPORTANCE Trypanosoma brucei causes human African trypanosomiasis and regu-

larly switches its major surface antigen, VSG, to evade the host immune response.
VSGs are expressed from subtelomeres in a monoallelic fashion. TbRAP1, a telomere
protein, is essential for cell viability and VSG monoallelic expression and suppresses
VSG switching. Although TbRAP1 has conserved functional domains in common with
its orthologs from yeasts to mammals, the domain functions are unknown. RAP1 orthologs have pleiotropic functions, and interaction with different partners is an important means by which RAP1 executes its different roles. We have established a
Cre-loxP-mediated conditional knockout system for TbRAP1 and examined the roles
of various functional domains in protein expression, nuclear localization, and
protein-protein interactions. This system enables further studies of TbRAP1 point
mutation phenotypes. We have also determined functional domains of TbRAP1 that
are required for several different protein interactions, shedding light on the underlying mechanisms of TbRAP1-mediated VSG silencing.
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elomeres are nucleoprotein complexes at linear chromosome ends. They are essential for genome integrity and chromosome stability (1). Telomere DNA in most
eukaryotic cells consists of TG-rich tandem repeats (2), and proteins that associate with
the telomere chromatin play critical roles in all aspects of telomere biology, including
telomere length regulation (3) and protection of the natural chromosome ends from
nucleolytic degradation and illegitimate DNA damage repair processes (1).
Among the core telomere protein components, RAP1 orthologs have been identiﬁed in many eukaryotes, including vertebrates (4–7), yeasts (8–15), and kinetoplastids
(16). RAP1 orthologs have similar functions in chromosome end protection (17–27),
telomere length control (4, 11, 17, 28–37), and telomeric silencing (12, 16, 34, 38–44) —
where the expression of genes located at subtelomeric regions are suppressed by the
heterochromatic telomere structure (45). Strikingly, RAP1 orthologs also have nontelomeric functions, including both transcription activation and repression activities (8,
46–55). In budding yeast, Saccharomyces cerevisiae RAP1 (ScRAP1) achieves different
goals through interactions with various protein partners (50). For example, the
C-terminal domain of ScRAP1 interacts with Sir3 and Sir4, which helps maintain
telomeric silencing (39, 56, 57), and the same region of ScRAP1 also interacts with Rif1
and Rif2 to regulate the telomere length (58, 59). Interestingly, RAP1 orthologs have
several conserved protein-protein interaction domains. All known RAP1s also have a
BRCA1 C terminus (BRCT) domain (4, 11, 12, 16) that is found in many proteins involved
in DNA damage repair and replication (60, 61) and that frequently interacts with
phosphorylated peptides (62–64). Human and yeast RAP1 orthologs also have a
C-terminal conserved domain termed RAP1 C terminus (RCT) (4, 65), which is mainly
involved in protein-protein interactions (39, 56–59, 66–68). All known RAP1 domains
have a central Myb domain (4, 11–13, 16, 69). Although ScRAP1 uses its Myb and
MybLike domains to bind duplex DNA directly (69), the human RAP1 Myb domain does
not have any DNA binding activity, as its third helix has a negatively charged surface
that is not suitable for DNA recognition (70).
A RAP1 ortholog has been identiﬁed in Trypanosoma brucei (16), a protozoan
parasite that causes human African trypanosomiasis. T. brucei proliferates in extracellular spaces of its mammalian host and is directly exposed to the host immune
surveillance. However, the parasite regularly switches its major surface antigen, variant
surface glycoprotein (VSG), thereby effectively evading the host immune response (71).
The T. brucei genome has ⬎2,500 VSG genes and pseudogenes (72), which are all
located at subtelomeres (72–74). VSGs are expressed exclusively from VSG expression
sites (ESs), which are subtelomeric polycistronic transcription units transcribed by RNA
polymerase I (RNA Pol I) (75, 76). VSG is the last gene in any ES, located within 2 kb of
the telomere repeats, while the ES promoter is 40 to 60 kb upstream (73). There are 13
different ESs in the Lister 427 strain (74), all with the same gene organization and with
⬃90% sequence identity (73). However, at any given moment, only one ES is fully
transcribed, presenting a single type of VSG on the cell surface (77). Monoallelic VSG
expression ensures the effectiveness of VSG switching by avoiding presentation of a
previously active VSG on the cell surface after a VSG switch, which helps the parasite
to establish long-term infections. Many factors have been shown to regulate monoallelic VSG expression, including chromatin structure, transcription elongation, inositol
phosphate pathway, and nuclear lamina (78, 79); a subtelomere and VSG-associated
VEX complex (80, 81); and telomeric silencing (16, 44). VSG switching has two major
pathways (82, 83). In an in situ switch, the originally active ES is silenced while a
different one becomes fully active (82, 83). In recombination-mediated switches, either
a silent VSG gene exchanges places with the originally active VSG without any loss of
genetic information or a silent VSG gene is duplicated into the active ES to replace the
originally active VSG gene (84). Many factors important for homologous recombination,
DNA damage repair, and DNA replication inﬂuence VSG switching frequencies (84).
Several telomere proteins also suppress VSG switching (85–88).
T. brucei RAP1 (TbRAP1) was identiﬁed as a factor interacting with T. brucei TTAGGG
repeat-binding factor (TbTRF) (16), which binds the duplex telomere DNA directly (89).
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TbRAP1 is essential for cell proliferation, and depletion of TbRAP1 leads to a dramatic
derepression of all ES-linked VSG genes up to ⬎1,000-fold (16, 44). Transient depletion
of TbRAP1 also results in an increased VSG switching frequency (88). Additionally,
depletion of TbRAP1 leads to an increased level of the telomeric transcript (TERRA), an
increased amount of telomeric RNA:DNA hybrids, and an elevated amount of telomeric/
subtelomeric DNA damage (88). We showed that TbRAP1 has a BRCT domain located
toward its N terminus, a central Myb domain, and a weak MybLike domain toward its
C terminus (16). Here, we report that TbRAP1 also has a C-terminal RCT domain.
However, functions of TbRAP1 domains are poorly understood. The interaction interface between TbRAP1 and TbTRF is unknown. Whether this interaction is required for
the nuclear localization of TbRAP1 is unclear. These limitations have hindered further
investigation of how TbRAP1 regulates VSG silencing and switching.
In this study, we established several strains in which one endogenous TbRAP1 allele
is ﬂanked by two loxP repeats so that it can be conditionally deleted by inducing Cre
expression. Using this system, we determined that TbRAP1 Myb is necessary for TbTRF
interaction and VSG silencing. Using TbRAP1 MybLike as bait in a yeast 2-hybrid screen,
we have determined that importin ␣ interacts with TbRAP1’s nuclear localization signal
(NLS) residing in the MybLike domain. We found that TbRAP1 interacts with itself
through the BRCT domain. In addition, the N terminus, BRCT, and RCT of TbRAP1 are
required for normal TbRAP1 protein levels, while Myb and MybLike are essential for
normal cell growth. These results not only provide further evidence of conserved
essential functions of RAP1 orthologs throughout evolution but also pave the way for
a better understanding of the mechanisms explaining how TbRAP1 silences subtelomeric VSG genes and helps maintain telomere stability and integrity.
RESULTS
Establishing a T. brucei strain with a ﬂoxed TbRAP1 allele. TbRAP1 is an essential
protein (16), making it difﬁcult to study phenotypes of various small deletions or point
mutations using RNA interference (RNAi) (90). To better characterize functions of
TbRAP1, we established a strain in which one TbRAP1 allele was ﬂanked by two loxP
repeats so that it was able to be conditionally deleted through Cre-mediated recombination (Fig. 1A). The other TbRAP1 allele can be replaced by various TbRAP1 mutants.
Upon induction of Cre by the use of doxycycline, we are able to examine the phenotypes of the mutant TbRAP1, even if they are lethal.
A loxP site with the hygromycin resistance gene (HYG) and a loxP site with the
blasticidin resistance gene (BSD) were targeted to locations upstream and downstream,
respectively, of a given TbRAP1 allele (Fig. 1A). Both selectable markers were fused with
the thymidine kinase gene (TK) from the herpes simplex virus, allowing selection for
cells that had lost the ﬂoxed TbRAP1 allele (denoted as “F”) by the use of ganciclovir
(GCV), as expression of the TK gene in T. brucei renders the parasite sensitive to GCV
(91). To enable selection of cells that had lost the ﬂoxed allele by the use of
ﬂuorescence-activated cell sorting (FACS) analysis, we also fused the green ﬂuorescent
protein gene (GFP) with both selectable markers (Fig. 1A). Therefore, cells carrying a
ﬂoxed TbRAP1 allele expressed HYG-GFP-TK and BSD-GFP-TK fusion proteins, and this
was conﬁrmed by Western analysis using a rabbit anti-GFP antibody (Life Technologies)
in two TbRAP1F/⫹ clones (without the Cre expression construct Cre-EP1 [91]) (see
Fig. S1A in the supplemental material). Southern blotting also conﬁrmed the genotype
of these clones (Fig. S1B).
To validate that the ﬂoxed TbRAP1 allele can be excised by Cre efﬁciently, we
transiently transfected the Cre-EP1 plasmid into TbRAP1F/⫹ (-Cre-EP1) cells. Pools of
cells and individual clones were selected with GCV. Western analysis performed with
the GFP antibody showed that HYG-GFP-TK and BSD-GFP-TK were no longer expressed
in either the pool or the clones (Fig. S1A). Southern analysis further conﬁrmed that the
ﬂoxed TbRAP1 allele was lost in the selected pool and clones (Fig. S1B).
To further increase the feasibility of conditional deletion of the ﬂoxed TbRAP1 allele,
we integrated Cre-EP1 into a ribosomal DNA (rDNA) spacer region, whose expression
January/February 2020 Volume 5 Issue 1 e00027-20
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FIG 1 Conditional knockout of T. brucei RAP1 (TbRAP1) led to cell growth arrest and VSG derepression. (A) A
diagram showing three different TbRAP1 alleles, including deleted (top), ﬂoxed (middle), and WT (bottom) alleles,
in TbRAP1F/⫺ (top two) and TbRAP1F/⫹ (bottom two) cells before (left) and after (right) the Cre induction. NT, N
terminus. (B) Western analysis of cell lysates prepared from TbRAP1F/⫺ cells before and after the Cre induction. A
rabbit antibody (16) was used to detect TbRAP1 (top). In this and other ﬁgures, TAT-1 (107) was used to detect
tubulin (as a loading control). (C) Quantitative RT-PCR was performed using TbRAP1 primers that anneal to the N
terminus or the BRCT domain of TbRAP1 (marked in panel A) to estimate the change in the TbRAP1 mRNA level
in TbRAP1F/⫹ and TbRAP1F/⫺ strains. (D) Growth curves of TbRAP1F/⫺ cells with and without the doxycyclineinduced Cre expression. (E) Quantitative RT-PCR to estimate the changes in mRNA level of a number of ES-linked
VSG genes and several control genes. Average values were calculated from three independent inductions. In this
and following ﬁgures, error bars represent standard deviations.

can be induced by doxycycline (91). The Cre-EP1-integrated TbRAP1F/⫹ cells grew
normally in the presence of phleomycin, hygromycin, and blasticidin (Fig. S1C). Upon
addition of doxycycline, these cells still grew normally in the presence of phleomycin
only but did not survive in the presence of all three antibiotics (phleomycin, hygromycin, and blasticidin) (Fig. S1C), conﬁrming that the doxycycline-induced Cre had
excised the ﬂoxed TbRAP1 allele together with the HYG-GFP-TK and BSD-GFP-TK markers. In the subsequent studies, the Cre-EP1 integrated TbRAP1F/⫹ strain was used.
Conditional deletion of TbRAP1 leads to cell growth arrest and VSG derepression. In TbRAP1F/⫹ cells, we replaced the unﬂoxed TbRAP1 allele with a puromycin
resistance marker (PUR) (Fig. 1A). In the resulting TbRAP1F/⫺ cells, addition of doxycycline led to the loss of the TbRAP1 protein in 48 h (Fig. 1B), conﬁrming the efﬁcient
deletion of the ﬂoxed TbRAP1 allele. The TbRAP1 mRNA level was estimated by
quantitative reverse transcription PCR (RT-PCR), and two sets of TbRAP1 primers were
used: one annealed speciﬁcally to the N-terminal region and another annealed to the
BRCT domain (Fig. 1A). After 24 h of Cre induction, the TbRAP1 mRNA level dropped to
10% of the wild-type (WT) level in TbRAP1F/⫺ cells (Fig. 1C), indicating that the sole
TbRAP1 allele in these cells was excised by Cre. In contrast, the TbRAP1 mRNA level
dropped to ⬃50% of the WT level in TbRAP1F/⫹ cells (Fig. 1C), as only the ﬂoxed TbRAP1
allele had been deleted, leaving the other WT allele intact.
We previously showed that depletion of TbRAP1 by RNAi led to cell growth arrest
and VSG derepression (16, 44). Induction of Cre in TbRAP1F/⫺ cells also led to a severe
growth defect (Fig. 1D). Quantitative RT-PCR analysis showed that ES-linked VSG6, VSG8,
VSG9, VSG11, VSG591, and VSG639 (all originally silent) were derepressed by several
10-fold orders after induction of Cre for 24 h and by several 100-fold orders after 48 h
(Fig. 1E). As a control, the rRNA levels and mRNA levels of two chromosome-internal
genes, SNAP50 and Tb11.0330, did not increase signiﬁcantly (Fig. 1E). The mRNA level of
the originally active VSG2 gene was decreased ⬃20% (Fig. 1E). Therefore, conditional
deletion of TbRAP1 by Cre-loxP exhibited the same phenotypes as depletion of TbRAP1
by RNAi (16), indicating that the Cre-loxP-mediated conditional deletion is feasible and
efﬁcient.
January/February 2020 Volume 5 Issue 1 e00027-20
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FIG 2 TbRAP1 has an RCT domain. (Top) TbRAP1 domain structure. The positions of each domain are
labeled. NT, N terminus; BRCT, BRCA1 C terminus; RCT, RAP1 C terminus. (Bottom) Sequence alignment
of the TbRAP1 RCT domain and the RCT domains in Saccharomyces cerevisiae (Sc) RAP1, Kluyveromyces
lactis (Kl) RAP1, Homo sapiens (Hs) RAP1, and Schizosaccharomyces pombe (Sp) RAP1 performed using
Clustal X. Alignment is visualized in SnapGene. Amino acid positions are indicated. Amino acids are
highlighted based on their properties and level of conservation (Clustal X). Speciﬁcally, nonpolar amino
acids are highlighted in blue, positively charged amino acids in red, negatively charged amino acids in
magenta, G amino acid (lacking of bonding characteristics) in orange, H and Y amino acids (mixture of
nonpolar and polar ends to the side chain) in dark turquoise, P amino acid (between polar and nonpolar)
in yellow, and S and T amino acids (mostly nonpolar) in green. Levels of conservation at each position
(percent identical residues among the ﬁve RAP1 orthologs) are shown as bar graphs on top of the aligned
sequences.

The TbRAP1 Myb domain is essential for normal cell growth and VSG silencing.
We previously showed that TbRAP1 has a BRCT domain, a Myb domain, and a MybLike
domain (Fig. 2, top) (16). With a careful sequence analysis, we found that the C terminus
of TbRAP1 has recognizable similarities to the RCT domains of other RAP1 orthologs
(Fig. 2, bottom). The level of sequence identity between TbRAP1 and other RAP1
orthologs in this domain was 11.7%, which is approximately the same as that in the
BRCT domain (16). We named this region “RCT.” Therefore, TbRAP1 has several conserved domains like other known RAP1 orthologs (Fig. 2, top).
The TbRAP1F/⫹ strain would be a good choice to examine phenotypes of various
TbRAP1 mutants lacking individual domains. As a proof of principle, in the TbRAP1F/⫹
strain, we replaced the WT TbRAP1 allele with a mutant that lacks the Myb domain.
Because the C-terminal FLAG-hemagglutinin-hemagglutinin (FLAG-HA-HA [F2H])tagged TbRAP1ΔMyb did not express well, we replaced the WT TbRAP1 allele with a
TbRAP1F2H-ΔMyb mutant (Fig. 3A). Western analysis using the HA probe antibody (Santa
Cruz Biotechnologies) showed that F2H-TbRAP1ΔMyb was expressed at the same level
as F2H-TbRAP1 from TbRAP1⫺/F2H⫹ cells (Fig. 3B; see also Table S1 in the supplemental
material). Southern blotting conﬁrmed the genotype of TbRAP1F/F2H-ΔMyb (Fig. S2A).
Using a TbRAP1 rabbit antibody (16) that recognizes a recombinant TbRAP1 fragment
containing only the MybLike domain (Fig. S2B), both WT TbRAP1 and F2H-TbRAP1ΔMyb
were observed by Western analysis at the same level in TbRAP1F/F2H-ΔMyb cells (Fig. 3C).
Upon induction of Cre, WT TbRAP1 was depleted whereas the expression of F2HTbRAP1ΔMyb remained the same (Fig. 3C). F2H-TbRAP1ΔMyb did not support normal
cell growth as TbRAP1F/F2H-ΔMyb cells exhibited a severe growth defect after Cre
induction (Fig. 3D), even though the mutant is located in the nucleus in immunoﬂuorescence (IF) analysis (Fig. 3E).
ScRAP1 has both transcription activation and repression functions (8, 50). To examine whether the Myb domain is required for VSG silencing and affects expression of
January/February 2020 Volume 5 Issue 1 e00027-20
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FIG 3 The Myb domain of TbRAP1 is essential for normal cell growth and VSG silencing. (A) Diagrams of
FLAG-HA-HA (F2H)-tagged WT and mutant TbRAP1 used in this study. NLS, simian virus 40 (SV40) large T nuclear
localization signal. NLSr, the second half of TbRAP1 nuclear localization signal (aa 737 to 742). (B) Whole-cell lysates
from TbRAP1F/F2H-mut cells (after induction of Cre for 30 h) and TbRAP1⫺/F2H⫹ cells (as a positive control) were
analyzed by Western blotting. HA probe monoclonal antibody (Santa Cruz Biotechnologies) was used to detect the
F2H-tagged TbRAP1. Red asterisks indicate the TbRAP1 fragments. F2H-TbRAP1ΔNT ran at a much lower rate than
expected. (C) Western blotting of cell lysates prepared from TbRAP1F/F2H-ΔMyb cells before and after induction of Cre.
An anti-TbRAP1 rabbit antibody (16) was used to detect TbRAP1 and F2H-TbRAP1ΔMyb. To differentiate WT and
mutant TbRAP1, proteins were separated on a 7.5% Tris polyacrylamide gel for 7 h 40 min. (D) Growth curves of
TbRAP1F/F2H-ΔMyb cells with and without the Cre induction. (E) F2H-TbRAP1ΔMyb is located in the nucleus. The
monoclonal HA antibody 12CA5 (Memorial Sloan Kettering Cancer Center [MSKCC] monoclonal antibody core) was
used to detect F2H-TbRAP1ΔMyb. An anti-VSG2 rabbit antibody (16) was used to show the outline of the cell body.
DAPI was used to stain DNA. The small DAPI-positive circle represents the kinetoplast (K), and the large
DAPI-positive circle represents the nucleus (N). Three different cells are shown in three panels. In this and other
ﬁgures, IF images are in the same scale and a size bar is shown in one of the panels. (F) Differential gene expression
in the TbRAP1ΔMyb mutant was summarized in a volcano plot. TbRAP1F/F2H-ΔMyb and TbRAP1F/⫹ cells were induced
for Cre expression for 30 h and analyzed by RNA-seq. Compared to TbRAP1F/⫹ cells, more than 8,000 genes were
upregulated and nearly 3,000 genes were downregulated in the Cre-induced TbRAP1F/F2H-ΔMyb cells. A
log10(adjusted P [padj]) value of 1.3 or higher is considered to be signiﬁcant.

other genes, we performed transcriptome sequencing (RNA-seq) analysis. Both
TbRAP1F/⫹ and TbRAP1F/F2H-ΔMyb cells were induced for Cre expression for 30 h, after
which the total RNA was isolated. Poly(A) RNA was puriﬁed and used for library
construction at Novogene followed by paired-end high-throughput sequencing using
Illumina (Materials and Methods). Differential gene expression analysis showed that
more than 8,000 genes were upregulated and nearly 3,000 genes were downregulated
in Cre-induced TbRAP1F/F2H-ΔMyb cells compared to the results seen with TbRAP1F/⫹
(Fig. 3F). However, the fold change in mRNA levels was much greater for upregulated
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FIG 4 Immunoﬂuorescent analysis of TbRAP1F/F2H-ΔMybL TRFi and TbRAP1F/F2H-NLS-ΔMybL TRFi cells. F2HTbRAP1ΔMybL and F2H-NLS-TbRAP1ΔMybL were stained with 12CA5 HA antibody. A rabbit VSG2
antibody was used to show the outline of the cell body. DNA was stained with DAPI. In each strain, three
different cells are shown in three panels.

genes than for downregulated ones (Fig. 3F), and upregulated genes were present in
much greater numbers than downregulated ones, suggesting that TbRAP1 has a major
role in gene silencing and a minor role in gene activation. Sequence read coverage in
all VSG bloodstream-form (BF) expression sites (BESs) (74) showed that all silent
BES-linked VSG genes and some BES-linked expression site-associated genes (ESAG
genes) were upregulated, but other BES-linked ESAG genes were not affected or were
even downregulated (Fig. S3). Based on available annotation of the affected genes, a
total of more than 2,700 VSG genes and pseudogenes were upregulated (Fig. S2C),
which included nearly all reported VSG genes/pseudogenes in the Lister 427 genome
(72). Therefore, the TbRAP1 Myb domain is essential for the functions of TbRAP1 in
normal cell growth and VSG silencing. Interestingly, the mRNA levels of some ribosomal
protein genes were decreased in the mutant, although at only up to 60% of the normal
level (Fig. S2D). It is possible that TbRAP1 may also participate in transcription activation
of ribosomal protein genes, as was seen previously with ScRAP1 (8), although further
investigation is necessary to validate this.
The nuclear localization signal of TbRAP1 is required for its interaction with
Importin ␣ and nuclear localization. Using the same approach, we replaced the WT
TbRAP1 allele with an F2H-tagged TbRAP1 mutant lacking the MybLike domain
(TbRAP1ΔMybL). Southern blotting conﬁrmed its genotype (Fig. S4A). Western blotting
showed that F2H-TbRAP1ΔMybL was expressed (Fig. S4B) and that the expression was
at the same level as F2H-TbRAP1 (Fig. 3B). However, IF showed that this mutant was
localized in the cytoplasm (Fig. 4A). Using Motif Scan analysis (https://myhits.isb-sib
.ch/cgi-bin/motif_scan) (92), we found that the sequence consisting of amino acids (aa)
727 to 741 of TbRAP1 represents a bipartite nuclear localization signal (NLS). F2HTbRAP1ΔMybL lacks this NLS, which is likely why this mutant is localized in the
cytoplasm. To conﬁrm this, we added the simian virus 40 (SV40) large T NLS to the N
terminus of TbRAP1ΔMybL (Fig. 3A). Southern and Western analyses conﬁrmed the
genotype of this strain and that the expression of F2H-NLS-TbRAP1ΔMybL was at the
WT level (Fig. 3B; see also Fig. S4C and D). IF analysis showed that F2H-NLSTbRAP1ΔMybL was indeed localized in the nucleus (Fig. 4B).
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FIG 5 The TbRAP1 MybLike domain is required for interaction with importin ␣. (A) Expression of importin
␣-myc13 in TbRAP1⫹/⫹, TbRAP1F2H⫹/⫹ TRFi, and TbRAP1F2H-ΔMybL/⫹ TRFi cells. Myc13-tagged proteins were
detected by a myc monoclonal antibody, 9E10 (MSKCC monoclonal antibody core). (B) Co-IP of TbRAP1
and importin ␣. The myc antibody 9E10, an anti-TbRAP1 rabbit antibody (16), and IgG (as a negative
control) were used for IP in TbRAP1⫹/⫹ cells. Western analysis was performed using the antibodies
mentioned above to detect importin ␣-myc13 and TbRAP1. In TbRAP1F2H⫹/⫹ TRFi and TbRAP1F2H-ΔMybL/⫹
TRFi cells, the 9E10 myc antibody, the 12CA5 HA antibody, and IgG (as a negative control) were used for
IP, and Western blotting was performed to detect importin ␣-myc13 (by 9E10) and F2H-tagged WT and
mutant TbRAP1 (by 12CA5 in the left panels and HA probe in the right panels). In this and other ﬁgures,
input samples represent 1% of the materials used for IP.

To further explore how TbRAP1 is imported into the nucleus, we screened a
normalized yeast 2-hybrid library generated from T. brucei cDNA using the TbRAP1
MybLike domain as bait. In this screen, 16.5 million yeast primary transformants were
obtained, and a total of 711 clones were positive in the initial screen. The majority of
the candidates represented the same gene, Tb427.06.2640, which is annotated as
encoding the importin ␣ subunit in TriTrypDB (93, 94). The canonical function of
importin ␣ is to bind the NLS of nuclear proteins, form a complex with importin ␤, and
transport the protein into the nucleus through the nuclear pore (95). Once inside the
nucleus, importin ␣ releases its cargo and exits the nucleus to transport the next cargo
(95). TbRAP1 MybLike contains the predicted bipartite NLS. Therefore, we expected that
importin ␣ would interact with the TbRAP1 NLS and this interaction would be essential
for transporting TbRAP1 into the nucleus.
To conﬁrm the interaction between importin ␣ and TbRAP1, we inserted a
C-terminal myc13 (13 repeats of myc) epitope at one endogenous importin ␣ allele. PCR
analysis conﬁrmed correct targeting in three different TbRAP1 backgrounds: both alleles
were WT, one of the two WT alleles had an N-terminal F2H tag, and one of the alleles
was replaced with the TbRAP1F2H-ΔMybL mutant (Fig. S5). The latter two strains also
carried an inducible TbTRF RNAi cassette inserted into an rDNA spacer, although the
RNAi was not induced for the analysis of TbRAP1-importin ␣ interaction. The expression
of importin ␣-myc13 was conﬁrmed by Western blotting (Fig. 5A). Subsequently, we
performed coimmunoprecipitation (co-IP) experiments in these three strains. In the
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TbRAP1⫹/⫹ background, IP experiments were performed using a rabbit TbRAP1 antibody (16) or the myc monoclonal antibody 9E10 (Memorial Sloan Kettering Cancer
Center [MSKCC] monoclonal antibody core). In TbRAP1F2H⫹/⫹ TRF RNAi (TRFi) and
TbRAP1F2H-ΔMybL/⫹ TRFi cells, IP experiments were performed using HA monoclonal
antibody 12CA5 (MSKCC monoclonal antibody core) or 9E10. In cells carrying untagged
or F2H-tagged WT TbRAP1, both importin ␣-myc13 and TbRAP1 were present in the IP
products (Fig. 5B, top two rows). However, F2H-TbRAP1ΔMybL and importin ␣-myc13
were not in the same IP product (Fig. 5B, bottom row). Therefore, the MybLike domain
of TbRAP1 (and most likely the NLS in this domain) is necessary for TbRAP1’s interaction
with importin ␣ and its nuclear localization.
The TbRAP1 Myb domain interacts with TbTRF. TbRAP1 was originally identiﬁed
as a TbTRF-interacting factor in a yeast 2-hybrid screen (16). The N-terminal part of
TbRAP1 (including the N terminus, BRCT, and Myb) is sufﬁcient to interact with TbTRF
in yeast 2-hybrid analysis (16), and WT TbRAP1 and TbTRF co-IP in vivo (16), although
both assays showed a weak interaction between the two proteins. To examine
which TbRAP1 functional domain(s) is essential for the TbRAP1-TbTRF interaction, in
the TbRAP1F/⫹ cells, we either targeted an F2H tag to the N terminus of the WT
TbRAP1 allele (to generate the TbRAP1F/F2H⫹ strain) or replaced the WT allele with
an F2H-tagged TbRAP1 mutant lacking various functional domains (to generate the
TbRAP1F/F2H-mut strains) (Fig. 3A). Southern analyses conﬁrmed the replacement of
the WT TbRAP1 allele by the TbRAP1F2H-ΔNT, TbRAP1F2H-ΔBRCT, or TbRAP1ΔMybLΔRCTF2H-NLSr allele in the corresponding strains (Fig. S6A to C). Here, we added the
second half (aa 736 to 742) of the endogenous TbRAP1 NLS (labeled as NLSr) at the
C terminus of TbRAP1ΔMybLΔRCT. These TbRAP1 mutants were expressed (Fig. 6A)
but at much lower levels than F2H-TbRAP1 (Fig. 3B). F2H-TbRAP1ΔNT and F2HTbRAP1ΔBRCT still contained the TbRAP1 NLS, and they were localized in the
nucleus as expected (Fig. 6B, left and middle). Interestingly, TbRAP1ΔMybLΔRCTF2H-NLSr was also localized in the nucleus (Fig. 6B, right), indicating that the
sequence consisting of aa 736 to 742 contains a minimum nuclear localization
signal and that its presence is sufﬁcient to target TbRAP1 to the nucleus. This
observation further validated the function of TbRAP1 NLS.
Since human RAP1 interacts with itself (4), it is possible that TbRAP1 may also
interact with itself (see below). To avoid detecting possible indirect interactions between TbTRF and mutant TbRAP1 mediated by the WT TbRAP1, we induced Cre in these
TbRAP1F/F2H-mut strains for 30 h to ensure the depletion of the WT TbRAP1 protein
(Fig. 6A). Depletion of TbRAP1 by RNAi for up to 36 h still allows complete cell growth
recovery 24 h after removal of the RNAi induction (88). In addition, upon Cre induction,
the number of TbRAP1F/⫺ and TbRAP1F/F2H-mut cells did not decrease for several days
(Fig. 1D) (Fig. 3D; see also Fig. S6D to G). Therefore, inducing TbRAP1F/F2H-mut for 30 h
caused only cell growth arrest rather than cell death. Subsequently, co-IPs were
performed using a rabbit TbTRF antibody (89). In all cases, TbTRF was detected in the
IP products by Western analysis using a chicken TbTRF antibody (16) (Fig. 6C, right).
Although F2H-TbRAP1ΔNT, F2H-TbRAP1ΔBRCT, and TbRAP1ΔMybLΔRCT-F2H-NLSr were
expressed at very low levels (Fig. 3B), these mutants still interacted with TbTRF, as they
were detected in the IP products in the same manner as F2H-TbRAP1 and F2H-NLSTbRAP1ΔMybL (Fig. 6C, left). However, F2H-TbRAP1ΔMyb was not detected in the IP
product (Fig. 6C, left). In addition, IF analysis showed that F2H-TbRAP1ΔMyb was not
colocalized with TbTRF even though these proteins were in the nucleus (Fig. 6D). As a
control, WT TbRAP1 was partially colocalized with TbTRF (Fig. 6D), as we have shown
previously (16). Therefore, the Myb domain of TbRAP1 is required for its interaction with
TbTRF. Interestingly, TbRAP1F/F2H-NLS-ΔMybL cells exhibited a growth arrest phenotype
after induction of Cre for 30 h (Fig. S6D), even though F2H-NLS-TbRAP1ΔMybL was
expressed at the WT level (Fig. 3B) and was localized in the nucleus (Fig. 4B), indicating
that the MybLike domain has essential functions other than transporting TbRAP1
into the nucleus. On the other hand, F2H-TbRAP1ΔNT, F2H-TbRAP1ΔBRCT, and
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FIG 6 The TbRAP1 Myb domain is required for interaction with TbTRF. (A) Western analyses showed the expression levels
of the F2H-tagged TbRAP1 mutants (using the HA probe antibody) and WT TbRAP1 (using a rabbit TbRAP1 antibody [16])
before and after the Cre induction in TbRAP1F/F2H-ΔNT, TbRAP1F/F2H-ΔBRCT, TbRAP1F/F2H-NLS-ΔMybL, and TbRAP1F/ΔMybLΔRCT-F2H-NLSr
cells. (B) IF analysis showed that F2H-TbRAP1ΔNT, F2H-TbRAP1ΔBRCT, and TbRAP1ΔMybLΔRCT-F2H-NLSr were localized in
the nucleus. 12CA5 was used to detect the F2H-tagged TbRAP1 mutants. A rabbit anti-VSG2 antibody was used to show the
outline of the cell body. DNA was stained by DAPI. In each strain, two different cells are shown in two panels. (C) Co-IP
experiments were performed in a series of TbRAP1F/F2H-mut cells (as labeled on the left). An anti-TbTRF rabbit antibody (89)
and IgG (as a negative control) were used for IP. The antibodies used for Western analyses of the IP products were the 12CA5
HA antibody (except for TbRAP1F/F2H-ΔNT, where the HA probe was used) and an anti-TbTRF chicken antibody (16). (D) (Top)
F2H-TbRAP1 (detected by 12CA5) partially colocalized with TbTRF (detected by a rabbit TbTRF antibody [89]) in TbRAP1⫺/
F2H⫹ cells. (Bottom) F2H-TbRAP1ΔMyb (detected by 12CA5) was not colocalized with TbTRF (detected by a chicken TbTRF
antibody [16]). DNA was stained by DAPI. Three different TbRAP1F/F2H-ΔMyb cells are shown.

TbRAP1ΔMybLΔRCT-F2H-NLSr were expressed at much lower levels than WT TbRAP1
(Fig. 3B), indicating that the N terminus and BRCT and RCT domain of TbRAP1 are
required for normal TbRAP1 protein levels, which is likely the reason why TbRAP1F/F2H-ΔNT,
TbRAP1F/F2H-ΔBRCT, and TbRAP1F/ΔMybLΔRCT-F2H-NLSr cells also showed a growth arrest phenotype after induction of Cre (Fig. S6E to G).
The BRCT domain is required for TbRAP1 self-interaction. To test whether
TbRAP1 has any self-interaction ability, we performed co-IP experiments in cells expressing an F2H-TbRAP1 from one of its endogenous alleles. Since TbRAP1 interacts
with TbTRF, these co-IP experiments were performed in TbTRF RNAi cells. Both before
and after depletion of TbTRF by RNAi (Fig. 7A, right), we detected WT TbRAP1 in the IP
product when IP was performed using the 12CA5 HA antibody (Fig. 7A, left). Therefore,
TbRAP1 interacts with itself, and this interaction is independent of TbTRF.
To further examine which domain of TbRAP1 is required for its self-interaction,
we tested whether any F2H-tagged TbRAP1 domain deletion mutants showed co-IP
with the WT TbRAP1. In TbRAP1F/F2H-mut cells (without Cre induction) and in
TbRAP1F2H-NLS-ΔMybL/⫹ TRFi cells, IP experiments were performed using the 12CA5 HA
antibody, and the IP products were examined by Western blotting using both the HA
probe antibody (Fig. 7B, right) and the rabbit TbRAP1 antibody (16) (Fig. 7B, left). In all
cells except TbRAP1F/F2H-ΔBRCT, WT TbRAP1 was detected in the IP products (Fig. 7B,
left), indicating that BRCT is essential for TbRAP1 self-interaction. Although F2HJanuary/February 2020 Volume 5 Issue 1 e00027-20
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FIG 7 TbRAP1 interacts with itself through the BRCT domain. (A) TbRAP1’s self-interaction activity is
independent of TbTRF. Left, co-IP experiments were done using the 12CA5 HA antibody and IgG (as a
negative control) in TbRAP1F2H⫹/⫹ TRFi cells before and after induction of TbTRF RNAi. IP products were
analyzed by Western blotting using a rabbit TbRAP1 antibody (16). To differentiate F2H-TbRAP1 and the
untagged TbRAP1, proteins were separated on a 7.5% Tris polyacrylamide gel for 7 h. Right, Western
analysis showed that TbTRF was efﬁciently depleted by RNAi after addition of doxycycline (Dox) for 30 h.
A rabbit antibody was used to detect TbTRF (89). (B) The BRCT domain of TbRAP1 is critical for its
self-interaction. Co-IP experiments were performed in various TbRAP1F/F2H-mut strains (indicated on the
left) without Cre induction and in TbRAP1F2H-NLS-ΔMybL/⫹ TRFi cells. IP experiments were done using the
12CA5 HA antibody and IgG (as a negative control). To analyze the IP products, WT TbRAP1 and
F2H-TbRAP1ΔMyb were detected with an anti-TbRAP1 rabbit antibody (16), and other F2H-tagged
TbRAP1 mutants were detected by the HA probe antibody in Western blotting. To differentiate TbRAP1
and F2H-TbRAP1ΔMyb, proteins were separated on a 7.5% Tris polyacrylamide gel for 7 h 40 min.

TbRAP1ΔBRCT was expressed at a lower-than-WT level, it was expressed at a higher
level than F2H-TbRAP1ΔNT and TbRAP1ΔMybLΔRCT-F2H-NLSr (Fig. 3B), while the latter
two mutants interacted with the WT protein (Fig. 7B, left). Therefore, the lack of
interaction between F2H-TbRAP1ΔBRCT and WT TbRAP1 is unlikely to have been due to
the low level of expression of the mutant.
DISCUSSION
RAP1 orthologs are conserved from protozoa to mammals (4–16), and they have
similar domain structures (4, 12, 16, 65) and essential telomeric and nontelomeric
functions (96). TbRAP1 also has the BRCT, Myb, MybLike, and RCT functional domains,
like other RAP1 orthologs (16). TbRAP1 is essential for VSG silencing and telomere/
subtelomere integrity and stability (16, 44, 88). However, whether TbRAP1’s domains
are required for these functions was unknown. Study of TbRAP1 domain functions was
partly limited by the fact that TbRAP1 is essential for cell proliferation (16). Previous
studies of TbRAP1 functions were heavily dependent on the use of conditional RNAi to
deplete TbRAP1 (16, 44, 88). Although expressing double-stranded RNA (dsRNA) of the
TbRAP1 full-length gene (16, 88), the BRCT fragment, or the RCT fragment (44) can
efﬁciently deplete TbRAP1, expressing dsRNA of the 3= untranslated region (3=UTR) of
TbRAP1 cannot. Therefore, the RNAi approach is not suitable for studying phenotypes
of all domain deletion mutants or point mutations of TbRAP1. In this study, we took
advantage of the Cre-loxP system (91) and established a series of strains in which one
endogenous TbRAP1 allele is ﬂanked by two repeats of loxP, allowing its conditional
deletion upon Cre induction. We conﬁrmed that this conditional deletion was able to
efﬁciently deplete the TbRAP1 protein and mRNA. Most importantly, we are now able
to examine the phenotypes of a series of TbRAP1 mutants that lack individual functional domains or carry point mutations, even if the mutants are lethal.
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In this study, we found that none of the domain deletion mutants of TbRAP1
could support normal cell growth. F2H-TbRAP1ΔNT, F2H-TbRAP1ΔBRCT, and
TbRAP1ΔMybLΔRCT-F2H-NLSr were expressed at much lower levels than the WT
TbRAP1, while F2H-TbRAP1ΔMyb, F2H-TbRAP1ΔMybL, and F2H-NLS-TbRAP1ΔMybL
were expressed at the same level as WT TbRAP1. Therefore, the N terminus, BRCT, and
RCT are required for normal TbRAP1 protein level, and the low level of protein
expression is most likely the reason why these mutants do not support normal cell
growth. F2H-TbRAP1ΔMyb and F2H-NLS-TbRAP1ΔMybL were localized in the nucleus
and expressed at the same level as the WT protein, but these mutants still had a severe
growth defect, indicating that Myb and MybLike domains are essential for normal cell
growth. Only the DNA binding domains of ScRAP1 (Myb and MybLike) are essential for
cell viability, and its RCT domain, which is important for telomere length regulation and
telomeric silencing, is not essential for cell survival (66). This leads us to speculate that
the TbRAP1 Myb and/or MybLike domains may have DNA binding activities. Although
Myb domains are frequently involved in DNA binding (97), the human RAP1 Myb
domain does not seem to have any DNA binding activity due to its negative surface
charge on the third helix, which is typically involved in DNA recognition (70). In
addition, the ScRAP1 MybLike domain was revealed to fold into a DNA binding motif
only after its crystal structure was solved (69). It will be interesting to investigate
whether TbRAP1 Myb and MybLike domains have any DNA binding activities, but
further protein structural analysis may be necessary.
Myb domains can also mediate protein-protein interactions (98, 99). We found that
TbRAP1 Myb interacts with TbTRF, providing another piece of evidence that the Myb
domain can have an important function in protein-protein interaction. Nevertheless,
whether the interaction between TbRAP1 and TbTRF is essential for cell survival and/or
VSG silencing is still unknown. Further investigation will be necessary to identify key
residues in TbRAP1 Myb that are critical for TbTRF interaction, which will help address
this issue. Human RAP1 uses its C-terminal RCT domain to interact with TRF2’s linker
region (4, 68). Similarly, Schizosaccharomyces pombe RAP1 also uses its C-terminal RCT
domain to interact with Taz1, a functional homologue of mammalian TRF1/2 (65, 68),
indicating that this interaction interface is conserved from yeast to mammals. However,
we found that the TbRAP1 Myb domain is critical for TbTRF interaction. It is interesting
that the RAP1-TRF interaction is preserved from kinetoplastids to mammals and yet the
functional domains that accomplish this goal have changed.
The transcription proﬁle of more than 10,000 genes was found to have changed in
TbRAP1F/F2H-ΔMyb cells after induction of Cre. In particular, ⬃2,700 VSG genes were
upregulated. Since the VSGnome identiﬁed more than 2,500 VSG genes and pseudogenes in the Lister 427 genome (72), this means nearly all of the VSG genes were
upregulated, further validating that TbRAP1 has an essential function in silencing VSG
genes and that Myb is essential for this function. Interestingly, RNA-seq also identiﬁed
nearly 3,000 genes that are downregulated in TbRAP1F/F2H-ΔMyb cells, although the fold
change in mRNA levels was much lower than that seen with the upregulated genes.
ScRAP1 has been well known for both its transcription activation and its repression
functions (50), and ScRAP1 is required for ribosomal protein gene activation (8). Our
observation suggests that TbRAP1 may have functions similar to those of ScRAP1,
although TbRAP1’s transcription activation effect appears to be much weaker than its
repressive effect. Some of the downregulated genes encode ribosomal proteins, suggesting that TbRAP1 may also participate in ribosomal protein gene activation. However, further validation is necessary to conﬁrm TbRAP1’s role as a transcription activator.
Importing ⬎45-kDa nuclear proteins frequently depends on the presence of NLS,
which can be recognized by importin ␣/␤ proteins (100). After the importin-cargo
complex is transported through the nuclear pore complexes, binding of RanGTP to the
importin ␤ dissociates the complex to release cargo into the nucleoplasm (100).
However, nuclear proteins can also be transported into the nucleus through NLSindependent mechanisms, such as interacting with a protein partner that contains a
NLS (101). TbRAP1 is a nuclear protein (16). However, how TbRAP1 is imported into the
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nucleus was unknown. Here, we show that importin ␣ directly interacts with TbRAP1
and that this interaction depends on the MybLike domain, which contains a predicted
bipartite NLS. Additionally, F2H-TbRAP1ΔMybL is not localized in the nucleus, while
TbRAP1ΔMybLΔRCT-F2H-NLSr with the second half of the TbRAP1 NLS, is. Therefore,
TbRAP1’s nuclear localization depends on the NLS in the MybLike domain and requires
its recognition by importin ␣. Addition of an SV40 large T NLS to the N terminus of
TbRAP1ΔMybL can target the mutant to the nucleus, indicating that the NLS and
importin ␣ are well conserved with other known classical NLS and importin ␣ proteins,
respectively. Interestingly, F2H-NLS-TbRAP1ΔMybL still interacts with TbTRF. However,
without any NLS, F2H-TbRAP1ΔMybL is localized in the cytoplasm, indicating that the
interaction between TbRAP1 and TbTRF is not sufﬁcient to bring TbRAP1 into the
nucleus.
Human RAP1 interacts with itself through the RCT domain (4), although the function
of this self-interaction is unknown. Human RAP1 interacts tightly with TRF2 with equal
stoichiometry (102), and TRF2 homodimerizes (103). It is possible that homodimerization of human RAP1 allows a better interaction with TRF2. The TbTRF-TbRAP1 interaction is much weaker than the TbTRF-TbTIF2 interaction (4, 86), and whether TbTRF
interacts with TbRAP1 with equal stoichiometry is unknown. Therefore, whether TbRAP1
self-interaction contributes to its interaction with TbTRF is not clear. We found that
TbRAP1’s self-interaction is independent of TbTRF, indicating that this self-interaction is
direct and not mediated by the TbRAP1-TbTRF interaction. Additionally, TbRAP1 selfinteraction and TbRAP1-TbTRF interaction require different functional domains. The
BRCT domain is also important for a normal level of TbRAP1 protein. It is possible that
TbRAP1 is better stabilized with self-interaction, possibly by preventing TbRAP1 degradation by proteases. Further analysis with point mutations in the BRCT domain that
speciﬁcally abolish TbRAP1 self-interaction will be useful to reveal its function and help
understand the mechanism of protein stabilization.
The fact that the functional interactions of RAP1 with other telomere proteins, such
as TRF, or with itself are conserved from kinetoplastids to mammals suggests that these
functions of RAP1 orthologs are critical for essential cellular processes. However,
throughout evolution, different organisms have used different approaches to achieve
the same goal. Hence, the detailed protein-protein interaction interfaces have been
changed even though the consequential protein complex is still preserved. We have
observed a similar scenario in interactions of TbTRF and TbTIF2 (86). Although TbTRF
interacts with TbTIF2 (86) and mammalian TRF1 and TRF2 interact with TIN2 (104, 105),
the two protein pairs interact with different interfaces (86). Therefore, conserved
protein-protein interactions without a conserved interaction interface can be common
among many telomere protein homologues.
TbRAP1, as with its orthologs in other organisms, has multiple protein-protein
interaction domains. A common theme appears to pertain for most RAP1 orthologs:
RAP1 interacts with different protein partners to perform different cellular tasks (50).
Our results further suggest that TbRAP1 interacts with different partners through
different functional domains to achieve various goals. With our established Cre-loxP
system, we will be able to investigate details of the functions of each TbRAP1 domain
in the future.
MATERIALS AND METHODS
T. brucei strains and plasmids. All T. brucei strains used in this study (listed in Table S1 in the
supplemental material) were derived from bloodstream-form Lister 427 cells that express VSG2 as well
as a T7 polymerase and the Tet repressor (also known as the single marker or SM strain) (106). All BF T.
brucei cells were cultured in HMI-9 medium supplemented with 10% fetal bovine serum (FBS) and
appropriate antibiotics.
To establish the TbRAP1F/⫹ strain, the NotI/XhoI-digested TbRAP1-5=UTR-loxP-HYGGFPTK plasmid and
NotI/XhoI-digested TbRAP1-3=UTR-BSDGFPTK-loxP plasmid were sequentially transfected into SM cells.
The A1 and A3 clones of TbRAP1F/⫹ (-Cre-EP1) were conﬁrmed by Western and Southern analyses (see
Fig. S1A and B in the supplemental material). The conditional Cre-expressing Cre-EP1 plasmid with the
phleomycin resistance (BLE) marker (91) was subsequently inserted into an rDNA spacer region to
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generate the ﬁnal TbRAP1F/⫹ strain. Clones A1 and B1 were veriﬁed by their sensitivity to hygromycin and
blasticidin after induction of Cre expression by the use of doxycycline (Fig. S1C).
To establish the TbRAP1F/⫺ strain, the NotI/XhoI-digested pSK-TbRAP1-ko-PUR plasmid was transfected into TbRAP1F/⫹ cells. The pSK-TbRAP1-ko-PUR plasmid contains PUR ﬂanked by sequences upstream and downstream of the TbRAP1 open reading frame (ORF), respectively.
All TbRAP1F/F2H-mut strains were established using the same strategy. N-terminal F2H-tagged
TbRAP1ΔNT, TbRAP1ΔBRCT, TbRAP1ΔMyb, TbRAP1ΔMybL, and NLS-TbRAP1ΔMybL mutants ﬂanked by
sequences upstream and downstream of the TbRAP1 gene, together with a PUR marker, were cloned into
pSK to generate respective targeting constructs. The TbRAP1ΔMybLΔRCT-F2H-NLSr mutant ﬂanked by
sequences upstream and downstream of the TbRAP1 gene was also cloned into pSK with a PUR marker
to generate the mutant targeting construct. All mutant targeting plasmids were digested with SacII (or
with PvuII in the case of ΔMybLΔRCT) before transfection of the TbRAP1F/⫹ cells was performed to
generate the corresponding TbRAP1F/F2H-mut strains. All mutant strains were conﬁrmed by Southern
analyses.
For examination of TbRAP1 self-interaction in the presence and absence of TbTRF, a TbTRF RNAi (TRFi)
strain was ﬁrst established by transfection of the NotI-digested pZJM␤-TbTRF-Mid1 RNAi construct (89)
into SM cells. Subsequently, one endogenous TbRAP1 allele was tagged with an N-terminal F2H tag by
transfection of a SacII-digested pSK-PUR-F2H-TbRAP1-tar2 construct into the TRFi cells.
Insertion of 13 C-terminal repeats of myc into one endogenous allele of importin ␣ was
performed in TbRAP1⫹/⫹, TbRAP1F2H⫹/⫹ TRFi, and TbRAP1F2H-ΔMybL/⫹ TRFi cells. TbRAP1F2H-ΔMybL/⫹
TRFi was obtained by replacing one endogenous TbRAP1 allele with the F2H-TbRAP1ΔMybL mutant
in TRFi cells as described above. (The TbRAP1F2H-NLS-ΔMybL/⫹ TRFi strain used for TbRAP1 co-IP analysis
was established in a similar way.) The importin ␣ C-terminal myc13 tagging fragment was ampliﬁed
by PCR with primers OBL-TbIMPORT-CT-MYC-FW (5=-GAGGGGGCACCTCAGCAGTTTGAGTTGGGGATG
GATCATGGAGATCCAAATGGACAGCCACCACAGGGCCAGTTCGATCTTATCCCCGGGTTAATTAACG-3=) and
OBL-TbIMPORT-CT-MYC-BW (5=-GTATATATATATACACGTGCCCTCCTTCTTCACCATTTTCATCCCTTTCATCTC
GATCTCATTATATTTATCAACTTTTCTCATCTAGATTCCTTTGCCC-3=) by the use of a plasmid containing
myc13 and a HYG marker as the template. The PCR product was then puriﬁed and transfected into
TbRAP1⫹/⫹, TbRAP1F2H⫹/⫹ TRFi, and TbRAP1F2H-ΔMybL/⫹ TRFi cells.
Coimmunoprecipitation. A total of 200 million T. brucei cells in log-phase growth were used for each
IP using appropriate antibody or IgG (as a negative control). IP products were pulled down by the use
of Dynabeads protein G (Life Technologies) and split equally for two Western blotting analyses using
appropriate antibodies. A 1% volume of input sample was loaded as a control. Since F2H-TbRAP1ΔNT,
F2H-TbRAP1ΔBRCT, and TbRAP1ΔMybLΔRCT-F2H-NLSr express at low levels, 500 million mutant cells
were used for each IP. A 1% volume of input was loaded in Western analysis as a control.
Immunoﬂuorescence analyses. IF experiments were performed as described previously (86). Speciﬁcally, cells were ﬁxed with 2% formaldehyde at room temperature for 10 min, permeabilized in 0.2%
NP-40 –1⫻ phosphate-buffered saline (PBS) at room temperature for 5 min and blocked by the use of 1⫻
PBS– 0.2% cold ﬁsh gelatin– 0.5% bovine serum albumin (BSA) at room temperature twice for 10 min each
time, followed by incubation with the primary antibody at room temperature for 2 h and the secondary
antibody at room temperature for 1 h. Cells were then washed with 1⫻ PBS– 0.2% cold ﬁsh gelatin– 0.5%
BSA and 1⫻ PBS followed by staining with 0.5 g/ml DAPI (4=,6-diamidino-2-phenylindole) and by
mounting of coverslips on slides. Images were taken by a DeltaVision Elite deconvolution microscope.
Images were deconvolved using SoftWoRx.
T. brucei cDNA library. A normalized T. brucei cDNA library was prepared by Bio S&T. Brieﬂy, using
a modiﬁed SMART cDNA synthesis method, the total RNA from WT T. brucei cells was used for synthesis
of cDNA with either oligo(dT) or a random primer. The cDNA was normalized and ampliﬁed, after which
it was inserted into a modiﬁed pGAD T7 yeast expression vector.
Yeast 2-hybrid screen. The TbRAP1 MybLike domain was cloned into the pBTM116 vector and
transformed into the yeast strain L41 [MAT␣ his 3D200 trp1-901 leu2-3,112 ade2 LYS::(lexAop)4-HIS3
URA3::(lexAop)8 –lacZ gal4 gal80]. The resulting cells were transformed with the normalized T. brucei cDNA
library. A total of 16.5 million primary transformants were plated onto synthetic drop-out (SD) plates
without tryptophan, leucine, or histidine. A total of 711 clones were obtained from this initial screening.
Subsequently, these clones were tested by the use of ﬁlter lift assays, and 508 candidates were veriﬁed
to express the reporter lacZ gene. The pGAD T7 candidate plasmids were isolated from these yeast
transformants and T. brucei gene insertions were analyzed by restriction digestion, PCR, and sequencing.
RNA-seq. Cre expression was induced by the use of doxycycline in TbRAP1F/F2H-ΔMyb and TbRAP1F/⫹
cells for 30 h, after which total RNA was isolated and puriﬁed through RNeasy columns (Qiagen). Three
independent inductions were performed as biological replicates. RNA samples were run on a BioAnalyzer
2100 system (Agilent Technologies) using an Agilent RNA 6000 Nano kit to verify the RNA quality and
then sent to Novogene for library preparation and RNA high-throughput sequencing.
The following processes were performed at Novogene.
(i) RNA quantiﬁcation and qualiﬁcation. RNA degradation and contamination were monitored on
1% agarose gels. RNA purity was checked using a NanoPhotometer spectrophotometer (Implen). RNA
integrity and quantitation were assessed using an RNA Nano 6000 assay kit on a Bioanalyzer 2100 system
(Agilent Technologies).
(ii) Library preparation for transcriptome sequencing. Sequencing libraries were generated using
a NEBNext Ultra RNA library prep kit for Illumina (NEB, USA) using 1 g poly(A) RNA according to the
manufacturer’s protocol, and index codes were added to attribute sequences to each sample. Brieﬂy,
mRNA was puriﬁed from total RNA using poly(T) oligonucleotide-attached magnetic beads. Fragmentamsphere.asm.org 14
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tion was carried out using divalent cations under conditions of elevated temperature in NEBNext
ﬁrst-strand synthesis reaction buffer (5⫻). First-strand cDNA was synthesized using random hexamer
primers and Moloney murine leukemia virus (M-MuLV) reverse transcriptase (RNase H-). Second-strand
cDNA synthesis was performed using DNA polymerase I and RNase H. The remaining overhangs were
converted into blunt ends via exonuclease/polymerase activities. After adenylation of 3= ends of DNA
fragments, NEBNext Adaptor with a hairpin loop structure was ligated to prepare for hybridization. In
order to select cDNA fragments preferentially of length 150 to 200 bp, the library fragments were puriﬁed
with an AMPure XP system (Beckman Coulter). A 3-l volume of USER Enzyme (NEB, USA) was used with
size-selected, adaptor-ligated cDNA at 37°C for 15 min followed by 5 min at 95°C followed by PCR, which
was performed with Phusion high-ﬁdelity DNA polymerase, universal PCR primers, and an Index (X)
primer. PCR products were puriﬁed (AMPure XP system), and library quality was assessed on an Agilent
Bioanalyzer 2100 system.
(iii) Clustering and sequencing (Novogene Experimental Department). Clustering of the indexcoded samples was performed on a cBot cluster generation system using a cBot-HiSeq (HS) paired-end
(PE) cluster kit (Illumina) according to the manufacturer’s instructions. After cluster generation, the library
preparations were sequenced on an Illumina platform and 125-bp and 150-bp paired-end reads were
generated.
RNA-seq data analysis. The RNA-seq data were analyzed by Novogene as follows.
(i) Quality control. Raw reads of fastq format were ﬁrst processed through the use of Novogene perl
scripts. In this step, clean reads were obtained by removing reads containing adapters, reads containing
poly(N), and low-quality reads. At the same time, the levels of Q20, Q30, and GC content of the clean reads
were calculated. All downstream analyses were performed on the basis of the clean reads with high quality.
(ii) Mapping of reads to the reference genome. The T. brucei Lister 427 genome TriTrypDB45_TbruceiLister427_2018_Genome.fasta and its annotation TriTrypDB-45_TbruceiLister427_2018.gff
were downloaded from TriTrypDB and used as the references. The index of the reference genome was
built using hisat2 2.1.0, and paired-end clean reads were aligned to the reference genome using HISAT2.
(iii) Quantiﬁcation of gene expression levels. HTSeq v0.6.1 was used to calculate the number of
reads mapped to each gene. The number of fragments per kilobase per million (FPKM) was calculated
for each gene on the basis of the length of the gene and the number of reads mapped to the gene.
(iv) Differential expression analysis. Differential expression analysis of two conditions/group (three
biological replicates per condition) was performed using the DESeq R package (1.18.0). The DESeq R
package provides statistical routines for determining differential expression in digital gene expression
data using a model based on the negative binomial distribution. The resulting P values were adjusted
using the Benjamini and Hochberg approach for controlling the false-discovery rate. Genes with an
adjusted P value of ⬍0.05 found by DESeq were assigned as differentially expressed.
Data availability. The RNA-seq data set determined in this work has been submitted to NCBI GEO
under accession number GSE143456.
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